Total Payments
$1.8M
2024 Payments
$432,514
Companies
52
Transactions
3,290
Medicare Patients
12,173
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$1.2M (65.9%)
Consulting$327,860 (18.1%)
Travel$227,766 (12.6%)
Food & Beverage$60,372 (3.3%)
Education$1,272 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 337 | 57.3% |
| Consulting Fee | $327,860 | 112 | 18.1% |
| Travel and Lodging | $227,766 | 592 | 12.6% |
| Honoraria | $85,700 | 19 | 4.7% |
| Food and Beverage | $60,372 | 2,192 | 3.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $46,550 | 10 | 2.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $23,400 | 7 | 1.3% |
| Education | $1,272 | 21 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $269,678 | 340 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $167,619 | 171 | $0 (2024) |
| ABBVIE INC. | $145,085 | 314 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $141,063 | 225 | $0 (2024) |
| PFIZER INC. | $129,952 | 242 | $0 (2019) |
| Arcutis Biotherapeutics, Inc. | $108,960 | 104 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $106,750 | 244 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $102,725 | 176 | $0 (2024) |
| GENZYME CORPORATION | $95,589 | 143 | $0 (2024) |
| Incyte Corporation | $85,973 | 121 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $432,514 | 535 | UCB, Inc. ($104,346) |
| 2023 | $469,080 | 575 | Arcutis Biotherapeutics, Inc. ($80,446) |
| 2022 | $265,214 | 502 | E.R. Squibb & Sons, L.L.C. ($60,012) |
| 2021 | $124,373 | 253 | UCB, Inc. ($30,922) |
| 2020 | $86,313 | 246 | UCB, Inc. ($33,391) |
| 2019 | $147,392 | 464 | UCB, Inc. ($61,633) |
| 2018 | $180,967 | 387 | PFIZER INC. ($64,779) |
| 2017 | $106,255 | 328 | PFIZER INC. ($65,051) |
All Payment Transactions
3,290 individual payment records from CMS Open Payments — Page 1 of 132
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $147.15 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,075.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $71.02 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 12/09/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $208.05 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $25.97 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,750.00 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $494.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Immunology | ||||||
| 11/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $99.19 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $7.65 | General |
| Category: Dermatology | ||||||
| 11/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $0.90 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,315 | 25,633 | $1.4M | $530,921 |
| 2022 | 26 | 3,104 | 8,680 | $887,552 | $313,727 |
| 2021 | 24 | 3,590 | 6,120 | $742,169 | $379,521 |
| 2020 | 21 | 3,164 | 6,472 | $749,494 | $356,717 |
Total Patients
12,173
Total Services
46,905
Medicare Billing
$1.6M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 34 | 731 | $342,313 | $147,585 | 43.1% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 34 | 768 | $239,462 | $103,393 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 510 | 852 | $210,749 | $71,845 | 34.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 364 | 538 | $117,381 | $41,055 | 35.0% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 40 | 19,807 | $49,518 | $25,668 | 51.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 34 | 157 | $51,513 | $23,583 | 45.8% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 34 | 703 | $50,454 | $21,439 | 42.5% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 40 | 105 | $38,304 | $17,412 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 163 | 163 | $53,513 | $15,943 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 363 | 523 | $68,147 | $14,380 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 193 | $33,807 | $11,629 | 34.4% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 33 | 105 | $14,657 | $6,752 | 46.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $10,168 | $3,827 | 37.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $10,115 | $3,748 | 37.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $9,158 | $3,447 | 37.6% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $10,978 | $2,966 | 27.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 46 | 161 | $7,113 | $2,725 | 38.3% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 32 | 46 | $5,169 | $2,325 | 45.0% |
| 29580 | Strapping, unna boot | Office | 2023 | 15 | 43 | $4,287 | $2,266 | 52.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 187 | 387 | $8,901 | $1,933 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 40 | $4,539 | $1,613 | 35.5% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 26 | 26 | $3,181 | $1,444 | 45.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 15 | $2,625 | $1,442 | 54.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $5,377 | $1,190 | 22.1% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 16 | 25 | $1,662 | $736.83 | 44.3% |
About Dr. George Drew, DO
Dr. George Drew, DO is a Dermatology healthcare provider based in Marion, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245298009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Drew, DO has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $432,514 received in 2024. These payments were reported across 3,290 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Drew has provided services to 12,173 Medicare beneficiaries, totaling 46,905 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Marion, OH
- Active Since 05/02/2006
- Last Updated 06/16/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245298009
Products in Payments
- DUPIXENT (Biological) $231,384
- EUCRISA (Drug) $128,292
- Sotyktu (Drug) $125,983
- Cimzia (Drug) $123,636
- TREMFYA (Drug) $115,639
- Bimzelx (Biological) $111,955
- SILIQ (Drug) $75,575
- OPZELURA (Drug) $74,894
- VTAMA (Drug) $64,754
- ILUMYA (tildrakizumab-asmn) injection (Biological) $62,249
- COSENTYX (Biological) $61,620
- RINVOQ (Biological) $58,130
- SPEVIGO (Drug) $55,116
- ADBRY (Biological) $43,928
- TALTZ (Drug) $37,191
- Humira (Biological) $35,040
- ILUMYA (Biological) $33,073
- Zoryve (Drug) $28,514
- DUOBRII (Drug) $26,636
- HUMIRA (Biological) $24,195
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.